Prenyl-IN-1

• Description :

  Prenyl-IN-1 is a protein prenylation inhibitor, especially a geranylgeranyltransferase (GGT) or a farnesyltransferase (FT) inhibitor, exhibiting potent activity against oxidative stress, and particularly in the treatment of Parkinson's Disease.

• UNSPSC :

  12352005

• Target :

  Farnesyl Transferase; GGTase

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/Benzonitrile,_4-[[5-[[4-_3-chlorophenyl_-3-oxo-1-piperazinyl]methyl]-1H-imidazol-1-yl]methyl]-2-phenoxy-.html

• Solubility :

  10 mM in DMSO

• Smiles :

  N#CC1=CC=C(CN2C(CN3CC(N(C4=CC=CC(Cl)=C4)CC3)=O)=CN=C2)C=C1OC5=CC=CC=C5

• Molecular Formula :

  C28H24ClN5O2

• Molecular Weight :

  497.98

• References & Citations :

  [1]Compounds which inhibits protein prenylation e.g. geranylgeranyltransferase or farnesyltransferase inhibitors for treating parkinson's disease. WO2006051423A1

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [360561-53-1]